LLY - Eli Lilly and Company - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LLY is currently covered by 21 analysts with an average price target of $1238.38. This is a potential upside of $137.72 (4.93%) from yesterday's end of day stock price of $1180.16.

Eli Lilly and Company's activity chart (see below) currently has 609 price targets and 488 ratings on display. The stock rating distribution of LLY is 93.85% BUY, 1.54% SELL and 4.62% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 89.9% with an average time for these price targets to be met of 251.09 days.

Highest price target for LLY is $1600, Lowest price target is $850, average price target is $1238.38.

Most recent stock forecast was given by ROBYN KARNAUSKAS from TRUIST on 07-Aug-2026. First documented stock forecast 11-Nov-2013.

Best performing analysts who are covering LLY - Eli Lilly and Company:

Courtney Breen Peter Verdult James Shin Trung Huynh Srikripa Devarakonda

Currently out of the existing stock ratings of LLY, 61 are a BUY (93.85%), 1 are a SELL (1.54%), 3 are a HOLD (4.62%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Nov-2021

$1376

$195.84 (16.59%)

$1370

Buy Since 14-Apr-2023

$1330

$149.84 (12.70%)

$1280

Buy Since 27-Feb-2020

$1410

$229.84 (19.48%)

$1350

Buy Since 13-Oct-2017

$1600

$419.84 (35.57%)

$1500

Buy Since 12-Dec-2024

$1385

$204.84 (17.36%)

$1100

Show more analysts

Please expand the browser size to see the chart

What is LLY (Eli Lilly and Company) average time for price targets to be met?

On average it took 251.09 days on average for the stock forecasts to be realized with a an average price target met ratio 89.9

Which analyst has the current highest performing score on LLY (Eli Lilly and Company) with a proven track record?

Which analyst has the most public recommendations on LLY (Eli Lilly and Company)?

has 0 price targets and 0 ratings on LLY

Which analyst is the currently most bullish on LLY (Eli Lilly and Company)?

Geoff Meacham with highest potential upside - $419.84

Which analyst is the currently most reserved on LLY (Eli Lilly and Company)?

Marc Goodman with lowest potential downside - -$854.47

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?